McAndrews’ Christopher Scharff and Valuation Expert Henry Kaskov Team Up for Built In Article


In “Why the Differences in Valuing Patents and Trade Secrets Matter,” this Built In story discusses considerations regarding how to value what is considered by many early stage companies their most valuable asset – their intellectual property. Trade secrets can be just as valuable as patents, so it’s important for startups to understand how both are valued and how potential investors view them.

Read the story here.